MedWatch

Biden wants to cut costs of prescription drugs in the US

President of the United States Joe Biden targeted insulin manufacturers like Novo Nordisk for overpricing drugs in his State of the Union Address on Tuesday.

The President of the United States Joe Biden | Photo: DREW ANGERER/AFP / GETTY IMAGES NORTH AMERICA

President of the United States Joe Biden wants to reduce the cost of prescription drugs in the US, he announced in his State of the Union Address on Tuesday evening local time.

Companies that sell insulin, which is Novo Nordisk’s primary product, were mentioned specifically in the speech.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs